Results 91 to 100 of about 374,365 (198)

Depot medroxyprogesterone acetate injection as contraceptive method

International Journal of Reproduction, Contraception, Obstetrics and Gynecology
Background: Depot medroxyprogesterone acetate (DMPA) injection is a reversible longer acting contraceptive method. One injection every three months makes compliance better and lesser side effects makes this contraception acceptable. Methods: This is a prospective study done at our institute between July 2021 to September 2023.
Riya R. Patel, Paresh N. Sheth, Anushka S. Mehta   +2 more
openaire   +1 more source

Breast Cancer and Depot-Medroxyprogesterone Acetate [PDF]

Obstetrical & Gynecological Survey, 1992
DAVID B. THOMAS, ELIZABETH A. NOONAN
openaire   +1 more source

Depot Medroxyprogesterone Acetate: Safety and Efficacy Update

Clinical Medicine Reviews in Women's Health, 2010
Depot medroxyprogesterone acetate (DMPA) is a long-acting, reversible progestin-only contraceptive method that is administered either intramuscularly or subcutaneously every 12 weeks. Because of its high efficacy, ease of use, privacy, and non-contraceptive benefits, adolescent and adult women are increasingly utilizing DMPA as their contraceptive ...
openaire   +1 more source

Genital Injury Signatures and Microbiome Alterations Associated With Depot Medroxyprogesterone Acetate Usage and Intravaginal Drying Practices

, 2017
Background. Increasing evidence suggests depot medroxyprogesterone acetate (DMPA) and intravaginal practices may be associated with human immunodeficiency virus (HIV-1) infection risk; however, the mechanisms are not fully understood.
Nilsson, Peter,, Nilsson, P, Bosire, Rose, Farquhar, C, Broliden, K,, Broliden, Kristina, Kiarie, J, Romas, Laura M., Birse, KD, Burgener, Adam D., Farquhar, Carey, Burgener, AD, Romas, LM, Kiarie, James, Birse, Kenzie D., Guthrie, BL, Guthrie, Brandon L., Bosire, R   +17 more
core   +1 more source

Impact of contraceptive initiation on the cervicovaginal mucosa: results from the UMPALA multicentre, partially randomized patient-preference interventional trial

Frontiers in Reproductive Health
BackgroundLong-acting contraceptives are widely used, providing superior efficacy and systemic safety; however, the impact of contraceptive initiation on female genital tract function and health has been understudied.MethodsNon-pregnant, HIV-uninfected ...
Betty Njoroge, Nelly Mugo, Nelly Mugo, Carolina Herrera, Karen Dominguez, Louise A. Ouattara, Nazita Yousefieh, Neelima Chandra, Agnieszka Kurczewska, Stephanie Nartey, Julie Lewis, Andrea R. Thurman, Matilda Saina, Raina N. Fichorova, Jacques Ravel, Reem Sharaf Alddin, Nicola Richardson-Harman, Kenneth Ngure, Kenneth Ngure, Gustavo F. Doncel   +19 more
doaj   +1 more source

Exploring the Reasons for Dropouts of Injectable Contraceptive in Burdwan Municipal area, West Bengal, India: Beneficiaries’ and Service Providers’ Perspectives

Current Medical Issues
Introduction: The inclusion of the Injectable Contraceptive, Antara Programme into family planning services signals a shift in the nation’s perspective and helps recipients achieve their goals for reproductive health.
Arif Hossain, Pramit Goswami, Kaushik Mitra, Pranita Taraphdar, Suman Sannigrahi, Soumik Dandapat   +5 more
doaj   +1 more source

A randomized crossover study to evaluate local tolerability following subcutaneous administration of a new depot medroxyprogesterone acetate contraceptive formulation. [PDF]

Contracept X, 2023
Halpern V, Wheeless A, Brache V, Lendvay A, Cochón L, Taylor D, Dorflinger LJ.   +6 more
europepmc   +1 more source

Case Report: Development of persistent genital arousal disorder due to a possible combination of medications

Frontiers in Psychiatry
ObjectivePersistent Genital Arousal Disorder (PGAD) is a rare and distressing condition characterized by persistent genital arousal in the absence of sexual desire.
Ludek Fiala, Ludek Fiala, Jiří Lenz, Jiří Lenz   +3 more
doaj   +1 more source

Depot-medroxyprogesterone acetate: Lipid profile changes and associated cardiovascular risks among acceptors in Sagamu, South West Nigeria. [PDF]

J Public Health Afr, 2023
Odelola O, Akadri A.
europepmc   +1 more source

Update on the Impact of Depot Medroxyprogesterone Acetate on Vaginal Mucosal Endpoints and Relevance to Sexually Transmitted Infections. [PDF]

Curr HIV/AIDS Rep, 2023
Dabee S, Balle C, Onono M, Innes S, Nair G, Palanee-Phillips T, Burgener AD, Bosinger SE, Passmore JS, Heffron R, Jaspan H, Happel AU.   +11 more
europepmc   +1 more source